Health.Global

how big is Health.Global?

As of October 2023, Healthcare Global Enterprises Ltd has a market capitalization of 7,641.00 Cr and reported net sales of 2,222.85 Cr and net profit of 44.41 Cr over the latest four quarters. Shareholder's funds are 825.78 Cr, with total assets of 2,700.44 Cr as of March 2024.

Market Cap: Healthcare Global Enterprises Ltd has a market capitalization of 7,641.00 Cr, categorizing it as a Mid Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters, which includes data from Mar'25, Dec'24, Sep'24, and Jun'24, is 2,222.85 Cr. The sum of Net Profit for the same period is 44.41 Cr. This data is Consolidated.<BR><BR>Balance Sheet Snapshot: This is Consolidated data for the latest annual period ending in Mar'24. The Shareholder's Funds amount to 825.78 Cr, and the Total Assets are valued at 2,700.44 Cr.

What does Health.Global do?

HealthCare Global Enterprises Ltd operates in the hospital industry, focusing on oncology services. As of March 2025, it reported net sales of 585 Cr and a net profit of 7 Cr, with a market cap of Rs 7,701 Cr.

Overview: <BR>Healthcare Global Enterprises Ltd operates in the hospital industry and is categorized as a mid-cap company.<BR><BR>History: <BR>The company was originally incorporated as Curie Centre of Oncology Private Limited in 1998. It changed its name to HealthCare Global Enterprises Private Limited in 2005 and became a public limited company, adopting its current name in 2006. The latest quarterly results reported net sales and profit for March 2025.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 585 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 7 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: Rs 7,701 Cr (Mid Cap)<BR><BR>Key Metrics: <BR>P/E: 172.00 <BR>Industry P/E: 54 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 1.61 <BR>Return on Equity: 4.81% <BR>Price to Book: 8.30 <BR><BR>Contact Details: <BR>Address: HCG Tower No 8 Kalinga Rao Rd, Sampangi Rama Nagar Bangalore Karnataka : 560027 <BR>Tel: 91-80-4660-7700 <BR>Email: sunumanuel@hcgoncology.com <BR>Website: http://www.hcgel.com

Who are in the management team of Health.Global?

As of March 2023, the management team of Health.Global includes Chairman/CEO Basavalinga Ajai Kumar Sadashivaiah, Executive Director Anjali Ajaikumar Rossi, and several independent and non-executive directors, overseeing the company's strategic direction and governance.

As of March 2023, the management team of Health.Global includes the following individuals:<BR><BR>1. BASAVALINGA AJAIKUMAR SADASHIVAIAH - Chairman/ED & CEO<BR>2. Siddharth Patel - Non Executive Director / Nomin<BR>3. Anjali Ajaikumar Rossi - Executive Director<BR>4. Geet Mathur - Independent Non Executive Director<BR>5. RAJAGOPALAN RAGHAVAN - Independent Non Executive Director<BR>6. Pradip M. Kanakia - Independent Non Executive Director<BR>7. Meghraj Arvindrao Gore - Whole Time Director & CEO<BR>8. AMIT SONI - Non Executive Director / Nomin<BR>9. Rajiv Maliwal - Independent Non Executive Director<BR>10. SUNU MANUEL - Company Secretary & Compliance Officer<BR><BR>This team is responsible for the strategic direction and governance of the company.

When is the next results date for Health.Global?

No Upcoming Board Meetings

Has Health.Global declared dividend?

No Dividend History Available

Who are the peers of the Health.Global?

Health.Global's peers include Max Healthcare, Apollo Hospitals, Fortis Health, Narayana Hrudaya, Global Health, Kovai Medical, Yatharth Hospital, Indraprastha Medical, and Artemis Medicare. Key metrics show varying management risks, growth rates, and capital structures, with Indraprastha Medical leading in 1-year returns at 78.47% and Global Health at the lowest with 4.29%.

Peers: The peers of Health.Global are Max Healthcare, Apollo Hospitals, Fortis Health., Narayana Hrudaya, Global Health, Kovai Medical, Yatharth Hospit., Indrapr.Medical, Artemis Medicare.<BR><BR>Quality Snapshot: Excellent management risk is observed at Max Healthcare, Apollo Hospitals, Narayana Hrudaya, Global Health, Kovai Medical, and Indrapr.Medical, while Average management risk is found at Fortis Health., Yatharth Hospit., and Artemis Medicare, and the rest have Below Average management risk. Excellent growth is seen at Max Healthcare and Apollo Hospitals, while Good growth is noted at Fortis Health., Narayana Hrudaya, Health.Global, Yatharth Hospit., and Indrapr.Medical, with Average growth at Global Health and Below Average growth at Kovai Medical and Artemis Medicare. Excellent capital structure is present at Max Healthcare, Global Health, and Indrapr.Medical, while Good capital structure is found at Fortis Health., Narayana Hrudaya, Kovai Medical, and Yatharth Hospit., and the rest have Average or Below Average capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Indrapr.Medical at 78.47%, while the lowest is Global Health at 4.29%. Health.Global's 1-year return of 54.56% is higher than Global Health's but lower than Indrapr.Medical's. Additionally, peers with negative six-month returns include Yatharth Hospit. and Artemis Medicare.

Who are the top shareholders of the Health.Global?

The top shareholders of Health.Global include Aceso Company Pte. Ltd. with 60.35%, followed by mutual funds at 9.19%, individual investors at 10.43%, and foreign institutional investors at 2.45%. The largest public shareholder is Tata India Pharma & Healthcare Fund, owning 3.42%.

The top shareholders of Health.Global include Aceso Company Pte. Ltd., which holds the largest stake at 60.35%. The promoters are the majority shareholders, with a pledged promoter holding of 4.995%. Additionally, mutual funds hold 9.19% of the shares across 9 schemes, while foreign institutional investors (FIIs) have a combined holding of 2.45% through 85 different entities. The highest public shareholder is Tata India Pharma & Healthcare Fund, which owns 3.42%. Individual investors collectively hold 10.43% of the company's shares.

How has been the historical performance of Health.Global?

Health.Global has shown strong growth in net sales, reaching 2,222.85 Cr in March 2025, with operating profit increasing to 387.28 Cr and a margin of 17.46%. However, profit before tax declined to 56.19 Cr, and the company faces cash management challenges despite improved operating cash flow.

Answer:<BR>The historical performance of Health.Global shows a significant upward trend in net sales and operating profit over the past several years, culminating in a net sales figure of 2,222.85 Cr for the year ending March 2025, up from 1,912.12 Cr in March 2024 and 1,694.44 Cr in March 2023. The total operating income has also increased consistently, reaching 2,222.85 Cr in March 2025. Operating profit, excluding other income, rose to 387.28 Cr in March 2025 from 329.59 Cr in March 2024, reflecting a healthy operating profit margin of 17.46%. However, profit before tax decreased to 56.19 Cr in March 2025 from 67.33 Cr in March 2024, leading to a profit after tax of 48.06 Cr, slightly up from 40.93 Cr the previous year. <BR><BR>In terms of assets and liabilities, total assets increased to 3,518.24 Cr in March 2025 from 2,700.44 Cr in March 2024, while total liabilities also rose to 3,518.24 Cr, indicating a balanced growth. The company’s total debt increased to 1,002.23 Cr in March 2025 from 672.76 Cr in March 2024. Cash flow from operating activities improved to 317.00 Cr in March 2025, although the net cash outflow was recorded at -213.00 Cr, indicating challenges in cash management. Overall, Health.Global has shown growth in sales and operating profit, but faces pressures on profitability and cash flow management.<BR><BR>Breakdown:<BR>Health.Global has demonstrated a robust growth trajectory in net sales, which reached 2,222.85 Cr in March 2025, marking a significant increase from 1,912.12 Cr in March 2024 and 1,694.44 Cr in March 2023. The total operating income mirrored this growth, also hitting 2,222.85 Cr in March 2025. Operating profit, excluding other income, rose to 387.28 Cr, up from 329.59 Cr the previous year, resulting in an operating profit margin of 17.46%. Despite this positive trend, profit before tax saw a decline to 56.19 Cr in March 2025 from 67.33 Cr in March 2024, leading to a profit after tax of 48.06 Cr, which is an increase from 40.93 Cr in the prior year. <BR><BR>On the balance sheet, total assets surged to 3,518.24 Cr in March 2025, compared to 2,700.44 Cr in March 2024, while total liabilities matched this figure, indicating a balanced growth. The total debt increased to 1,002.23 Cr in March 2025 from 672.76 Cr in March 2024. Cash flow from operating activities improved to 317.00 Cr, yet the company faced a net cash outflow of -213.00 Cr, highlighting ongoing challenges in cash management despite the growth in sales and operating profit.

Is Health.Global overvalued or undervalued?

As of November 24, 2025, Health.Global is considered undervalued with an attractive valuation grade, despite having a high PE ratio of 286.73 and an EV to EBITDA ratio of 27.53, while outperforming the Sensex with a 53.86% return over the past year.

As of 24 November 2025, Health.Global's valuation grade has moved from fair to attractive, indicating a more favorable assessment of its market position. The company is currently considered undervalued, especially when compared to its peers. Key ratios include a PE ratio of 286.73, an EV to EBITDA ratio of 27.53, and a ROCE of 7.64%. <BR><BR>In the peer comparison, Health.Global's PE ratio significantly exceeds that of Apollo Hospitals, which stands at 63.22, while its EV to EBITDA ratio is also higher than Apollo's 33.25. This suggests that Health.Global may be overvalued on a relative basis despite its attractive grade. Notably, the company's stock has outperformed the Sensex over the past year, returning 53.86% compared to the Sensex's 7.31%, reinforcing the notion of its strong market performance despite the high valuation ratios.

Is Health.Global technically bullish or bearish?

As of December 3, 2025, the trend is mildly bullish due to positive daily moving averages and Bollinger Bands, but caution is advised due to mixed signals from the MACD, KST, and monthly RSI.

As of 3 December 2025, the technical trend has changed from bullish to mildly bullish. The current stance is mildly bullish, driven by the daily moving averages indicating bullishness and the Bollinger Bands showing a mildly bullish signal on both weekly and monthly time frames. However, the MACD and KST on the weekly are mildly bearish, and the monthly RSI is bearish, suggesting some caution. Overall, the mixed signals indicate a mildly bullish outlook with underlying weaknesses that could affect momentum.

Are Healthcare Global Enterprises Ltd latest results good or bad?

Healthcare Global Enterprises Ltd's latest Q3 FY26 results are concerning, with a net profit of ₹-9.43 crores, a 157.96% QoQ decline, and a negative PAT margin of -1.25%. Despite a 13.34% YoY increase in net sales, the company faces significant operational challenges and deteriorating profitability metrics.

Healthcare Global Enterprises Ltd's latest results for Q3 FY26 indicate a challenging quarter for the company. The consolidated net profit has turned negative at ₹-9.43 crores, marking a significant decline of 157.96% quarter-over-quarter (QoQ) and a staggering 235.10% drop year-over-year (YoY). This sharp reversal from a profit of ₹16.27 crores in the previous quarter raises serious concerns about the company's operational efficiency and cost management.<BR><BR>While net sales for the quarter were ₹633.07 crores, reflecting a 13.34% increase YoY, there was a slight decline of 2.13% compared to the previous quarter. This suggests that despite maintaining some revenue growth, the company is struggling to convert that into profits, as evidenced by the operating margin decreasing to 17.37%, down 174 basis points QoQ.<BR><BR>The PAT margin has also turned negative at -1.25%, a stark contrast to the positive 3.20% in the prior quarter. This deterioration in profitability metrics, coupled with high debt levels and increased operational costs, paints a concerning picture for the company's financial health.<BR><BR>Overall, the results can be characterized as bad, highlighting significant operational challenges that need to be addressed for the company to regain profitability and investor confidence.

Should I buy, sell or hold Healthcare Global Enterprises Ltd?

Which are the latest news on Health.Global?

Why is Healthcare Global Enterprises Ltd falling/rising?

As of 17-Mar, Healthcare Global Enterprises Ltd's stock price is rising to 551.55, reflecting increased investor interest. However, the stock has underperformed its sector and shows significant long-term challenges, including a 16.40% year-to-date decline and concerns over management efficiency and profitability.

As of 17-Mar, Healthcare Global Enterprises Ltd's stock price is rising, currently at 551.55, with a change of 1.2 (0.22%) increase. This rise follows a two-day consecutive gain, during which the stock has returned 1.68%. Additionally, there has been a notable increase in investor participation, with delivery volume rising by 4.46% against the five-day average, indicating growing interest in the stock.<BR><BR>Despite this positive short-term performance, the stock has underperformed its sector by 0.33% today and is trading below its moving averages across various time frames, which suggests some underlying weakness. Over the longer term, the stock has shown a significant decline of 16.40% year-to-date, compared to a 10.74% decline in the benchmark Sensex, highlighting ongoing challenges.<BR><BR>While the company has demonstrated healthy long-term growth with an annual operating profit increase of 48.50%, it faces serious concerns regarding management efficiency and profitability, as indicated by a low Return on Capital Employed (ROCE) of 6.65% and a high Debt to EBITDA ratio of 3.40 times. Furthermore, the company's profits have decreased by 42.6% over the past year, and a significant portion of promoter shares (85.23%) are pledged, which can exert downward pressure on the stock price in a falling market.<BR><BR>In summary, while there is a short-term rise in the stock price due to increased investor interest and recent gains, the overall outlook remains cautious due to significant operational challenges and poor financial metrics.

Why is Healthcare Global Enterprises Ltd falling/rising?

As of 18-Mar, Healthcare Global Enterprises Ltd's stock price has risen to 562.00, reflecting a 2.07% increase. Despite recent gains, the company's long-term outlook is concerning due to a significant decline in profits, high debt levels, and low management efficiency.

As of 18-Mar, Healthcare Global Enterprises Ltd is experiencing a rise in its stock price, currently at 562.00, which reflects an increase of 11.4 (2.07%). This upward movement can be attributed to several factors. Notably, the stock has outperformed its sector by 0.77% today and has shown a consecutive gain over the last three days, accumulating a total return of 3.6% during this period. Additionally, the stock reached an intraday high of Rs 576.1, marking a rise of 4.63%.<BR><BR>Despite these positive short-term trends, it is important to consider the broader context of the company's performance. Over the past year, while the stock has generated a return of 13.95%, the company's profits have significantly declined by 42.6%. Furthermore, the stock is trading at a discount compared to its peers' average historical valuations, which may attract investors looking for value.<BR><BR>However, there are underlying concerns that could impact future performance. The company has a low Return on Capital Employed (ROCE) of 6.65%, indicating poor management efficiency and low profitability per unit of total capital. Additionally, the high Debt to EBITDA ratio of 3.40 times suggests a low ability to service debt, which could pose risks moving forward. The recent negative financial results, including a significant drop in profit after tax and a low earnings per share, also raise caution.<BR><BR>In summary, while Healthcare Global Enterprises Ltd is currently rising in price due to recent gains and sector outperformance, the long-term outlook is tempered by declining profits, high debt levels, and management efficiency issues.

Why is Healthcare Global Enterprises Ltd falling/rising?

As of 19-Mar, Healthcare Global Enterprises Ltd's stock price is declining at 549.75, down 3.1%, due to underperformance in its sector, a trend reversal after previous gains, and poor financial health indicators. The company faces reduced investor interest, high debt levels, and significant profit declines, contributing to a bearish market sentiment.

As of 19-Mar, Healthcare Global Enterprises Ltd is experiencing a decline in its stock price, currently at 549.75, which reflects a change of -17.6 or -3.1%. This downward movement can be attributed to several factors. Firstly, the stock has underperformed its sector by -0.28% today and opened with a significant loss of -3.05%. Additionally, it reached an intraday low of Rs 540.2, marking a decrease of -4.79%. <BR><BR>The stock has also shown a trend reversal, falling after three consecutive days of gains, indicating a shift in market sentiment. Furthermore, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which suggests a bearish trend. The overall performance of the Hospital & Healthcare Services sector has declined by -2.63%, contributing to the negative sentiment surrounding the stock.<BR><BR>Investor participation appears to be waning, with delivery volume dropping by -14.9% compared to the 5-day average, signaling reduced interest from investors. The company's financial health is also a concern, as it has a high Debt to EBITDA ratio of 3.40 times, indicating a low ability to service debt, and a low Return on Capital Employed (ROCE) of 6.65%, which reflects poor management efficiency. <BR><BR>Moreover, the company has reported a significant decline in profits, with a -42.6% drop in profits over the past year, despite a positive return of 10.56% on the stock. The latest financial results show a PAT of Rs 19.51 crore, which has grown at -21.87%, further exacerbating investor concerns. Additionally, a high percentage of promoter shares (85.23%) are pledged, which can put additional downward pressure on the stock in a falling market.<BR><BR>Overall, these factors collectively contribute to the stock's decline, reflecting a challenging environment for Healthcare Global Enterprises Ltd.

Why is Healthcare Global Enterprises Ltd falling/rising?

As of 20-Mar, Healthcare Global Enterprises Ltd's stock price is at 545.90, down 0.82%, and has underperformed its sector. The company faces challenges with low ROCE, high debt levels, and a significant decline in profits, contributing to its bearish trend.

As of 20-Mar, Healthcare Global Enterprises Ltd's stock price is falling, currently at 545.90, reflecting a decrease of 4.5 points or 0.82%. The stock has underperformed its sector by 1.38% today and has experienced a consecutive decline over the last two days, resulting in a total drop of 3.78% during this period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend.<BR><BR>Despite a healthy long-term growth rate in operating profit of 48.50%, the company faces significant challenges. Its Return on Capital Employed (ROCE) is low at 6.65%, suggesting poor management efficiency and low profitability per unit of capital. Furthermore, the company has a high Debt to EBITDA ratio of 3.40 times, indicating a low ability to service its debt. This financial strain is compounded by a substantial decline in profits, with a reported 42.6% decrease over the past year.<BR><BR>Moreover, the stock's performance has been negatively impacted by the high percentage of pledged promoter shares, which stands at 85.23%. In a declining market, this situation can exert additional downward pressure on the stock price. The recent negative results, including a 21.87% decline in profit after tax and the lowest earnings per share at Rs -0.66, further contribute to the stock's downward trajectory. Overall, these factors collectively explain the current decline in Healthcare Global Enterprises Ltd's stock price.

Why is Healthcare Global Enterprises Ltd falling/rising?

As of 23-Mar, Healthcare Global Enterprises Ltd's stock price is declining, currently at Rs 524.00, reflecting a 3.5% decrease. The stock has underperformed its sector and shows negative financial indicators, including a significant profit drop and high debt levels, contributing to a bearish trend.

As of 23-Mar, Healthcare Global Enterprises Ltd's stock price is falling, currently at Rs 524.00, which reflects a decrease of Rs 19.0 or 3.5%. The stock has underperformed its sector by 1.1% today and has been on a downward trend for the last three days, accumulating a total decline of 7.64% during this period. The stock opened with a loss of 2.22% today and reached an intraday low of Rs 520, which is 4.82% away from its 52-week low of Rs 498.74672.<BR><BR>In terms of broader performance, the stock has shown a year-to-date decline of 20.57%, significantly worse than the Sensex's decline of 14.70%. Additionally, the stock is trading below all its moving averages, indicating a bearish trend. The recent drop in investor participation, with delivery volume falling by 58.67% compared to the 5-day average, further suggests a lack of confidence among investors.<BR><BR>Negative financial indicators also contribute to the stock's decline. The company has reported a significant drop in profits, with a 42.6% decrease over the past year, and its return on capital employed (ROCE) is low at 6.65%. Furthermore, a high Debt to EBITDA ratio of 3.40 times indicates a low ability to service debt, which raises concerns about the company's financial health. The fact that 85.23% of promoter shares are pledged adds additional pressure on the stock price, especially in a declining market.<BR><BR>Overall, these factors collectively explain why Healthcare Global Enterprises Ltd's stock is currently falling.

Why is Healthcare Global Enterprises Ltd falling/rising?

As of 24-Mar, Healthcare Global Enterprises Ltd's stock price is rising to 526.50, indicating a potential trend reversal after previous declines. Despite this short-term recovery, the stock has underperformed its sector and faces long-term challenges, including poor management efficiency and high debt levels.

As of 24-Mar, Healthcare Global Enterprises Ltd's stock price is rising, currently at 526.50, reflecting a change of 5.6 (1.08%) upward. This rise comes after three consecutive days of decline, indicating a potential trend reversal. The stock reached an intraday high of Rs 543.85, which is a 4.41% increase, suggesting some recovery in investor sentiment.<BR><BR>Despite the positive movement today, the stock has underperformed its sector by 1.27%. However, there has been a notable increase in investor participation, with delivery volume rising by 15.28% compared to the five-day average, which may indicate growing interest among investors.<BR><BR>On a broader scale, while the stock has faced challenges, including a significant year-to-date decline of 20.20% compared to a 13.09% drop in the benchmark Sensex, it has shown strong long-term growth potential, with an annual operating profit growth rate of 48.50%. The stock is also trading at a discount relative to its peers, which may attract value investors.<BR><BR>However, it is important to note that the company faces several negative factors, including poor management efficiency and a high Debt to EBITDA ratio, which could impact its long-term performance. Additionally, the high percentage of pledged promoter shares could exert downward pressure on the stock in a falling market. Overall, the current rise in the stock price appears to be a short-term recovery amidst a backdrop of longer-term challenges.

Why is Healthcare Global Enterprises Ltd falling/rising?

As of 25-Mar, Healthcare Global Enterprises Ltd's stock price is rising to 540.25, reflecting a 2.61% increase. However, despite this short-term gain, the company faces significant long-term financial challenges, including a year-to-date decline of 18.11% and concerns over management efficiency and high debt levels.

As of 25-Mar, Healthcare Global Enterprises Ltd's stock price is rising, currently at 540.25, reflecting an increase of 13.75 (2.61%). This upward movement can be attributed to several factors. Firstly, the stock has outperformed its sector by 0.34% today and has shown a consecutive gain over the last two days, with a total return of 3.71% during this period. Additionally, the stock reached an intraday high of Rs 543.8, indicating positive trading momentum.<BR><BR>Despite this recent rise, it is important to note that the stock has experienced a decline over longer periods, with a year-to-date drop of 18.11% compared to a 11.67% decline in the Sensex. The stock's performance over the past month also shows a decrease of 6.48%. Furthermore, while the stock has generated a return of 3.03% over the past year, its profits have significantly fallen by 42.6%, which raises concerns about its long-term viability.<BR><BR>The company is facing challenges such as low management efficiency, indicated by a Return on Capital Employed (ROCE) of 6.65%, and a high Debt to EBITDA ratio of 3.40 times, suggesting difficulties in servicing its debt. Additionally, a significant portion of promoter shares, 85.23%, are pledged, which can exert downward pressure on the stock in a falling market.<BR><BR>In summary, while Healthcare Global Enterprises Ltd is currently experiencing a rise in stock price due to short-term trading gains and sector outperformance, the underlying financial challenges and historical performance trends indicate potential risks that could affect its future stability.